Was the flu drug zanamivir a breakthrough or money for old rope? While Relenza's benefits are modest at best, its story would make a great Hollywood blockbuster

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalComment/debate/opinionResearchpeer-review

2 Citations (Scopus)
Original languageEnglish
Article numberg3611
Number of pages2
JournalBritish Medical Journal
Publication statusPublished - 2 Jun 2014

Cite this